Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Type I IFN promotes IL-10 production from T cells to suppress Th17 cells and Th17-associated autoimmune inflammation.

Zhang L, Yuan S, Cheng G, Guo B.

PLoS One. 2011;6(12):e28432. doi: 10.1371/journal.pone.0028432. Epub 2011 Dec 6.

2.

Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.

Rostami A, Ciric B.

J Neurol Sci. 2013 Oct 15;333(1-2):76-87. doi: 10.1016/j.jns.2013.03.002. Epub 2013 Apr 8. Review.

3.

Using EAE to better understand principles of immune function and autoimmune pathology.

Rangachari M, Kuchroo VK.

J Autoimmun. 2013 Sep;45:31-9. doi: 10.1016/j.jaut.2013.06.008. Epub 2013 Jul 9. Review.

4.

Th17 Cells and autoimmune encephalomyelitis (EAE/MS).

Aranami T, Yamamura T.

Allergol Int. 2008 Jun;57(2):115-20. doi: 10.2332/allergolint.R-07-159. Review.

5.

Current status of the immunomodulation and immunomediated therapeutic strategies for multiple sclerosis.

Chen SJ, Wang YL, Fan HC, Lo WT, Wang CC, Sytwu HK.

Clin Dev Immunol. 2012;2012:970789. doi: 10.1155/2012/970789. Epub 2011 Dec 6. Review.

6.

Interleukin 12 (IL-12) family cytokines: Role in immune pathogenesis and treatment of CNS autoimmune disease.

Sun L, He C, Nair L, Yeung J, Egwuagu CE.

Cytokine. 2015 Oct;75(2):249-55. doi: 10.1016/j.cyto.2015.01.030. Epub 2015 Mar 18. Review.

7.

Janus-like effects of type I interferon in autoimmune diseases.

Axtell RC, Raman C.

Immunol Rev. 2012 Jul;248(1):23-35. doi: 10.1111/j.1600-065X.2012.01131.x. Review.

8.

Seeking balance: Potentiation and inhibition of multiple sclerosis autoimmune responses by IL-6 and IL-10.

Ireland SJ, Monson NL, Davis LS.

Cytokine. 2015 Jun;73(2):236-44. doi: 10.1016/j.cyto.2015.01.009. Epub 2015 Mar 17. Review.

9.

Type I interferons: beneficial in Th1 and detrimental in Th17 autoimmunity.

Axtell RC, Raman C, Steinman L.

Clin Rev Allergy Immunol. 2013 Apr;44(2):114-20. doi: 10.1007/s12016-011-8296-5. Review.

10.

Th17 cell cytokine secretion profile in host defense and autoimmunity.

Graeber KE, Olsen NJ.

Inflamm Res. 2012 Feb;61(2):87-96. doi: 10.1007/s00011-011-0419-1. Epub 2011 Dec 25. Review.

PMID:
22197935
11.

Stage-Specific Role of Interferon-Gamma in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.

Arellano G, Ottum PA, Reyes LI, Burgos PI, Naves R.

Front Immunol. 2015 Sep 29;6:492. doi: 10.3389/fimmu.2015.00492. eCollection 2015. Review.

12.

Interferon-β exacerbates Th17-mediated inflammatory disease.

Axtell RC, Raman C, Steinman L.

Trends Immunol. 2011 Jun;32(6):272-7. doi: 10.1016/j.it.2011.03.008. Epub 2011 Apr 29. Review.

13.

The Interleukin (IL)-23/T helper (Th)17 Axis in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.

Hiltensperger M, Korn T.

Cold Spring Harb Perspect Med. 2018 Jan 2;8(1). pii: a029637. doi: 10.1101/cshperspect.a029637. Review.

PMID:
29101111
14.

Progesterone and autoimmune disease.

Hughes GC.

Autoimmun Rev. 2012 May;11(6-7):A502-14. doi: 10.1016/j.autrev.2011.12.003. Epub 2011 Dec 13. Review.

15.

Endothelial-binding, proinflammatory T cells identified by MCAM (CD146) expression: Characterization and role in human autoimmune diseases.

Dagur PK, McCoy JP Jr.

Autoimmun Rev. 2015 May;14(5):415-22. doi: 10.1016/j.autrev.2015.01.003. Epub 2015 Jan 13. Review.

16.

Th17 pathway-mediated immunopathogenesis of schizophrenia: mechanisms and implications.

Debnath M, Berk M.

Schizophr Bull. 2014 Nov;40(6):1412-21. doi: 10.1093/schbul/sbu049. Epub 2014 Apr 7. Review.

17.

Innately versatile: γδ17 T cells in inflammatory and autoimmune diseases.

Papotto PH, Reinhardt A, Prinz I, Silva-Santos B.

J Autoimmun. 2017 Dec 1. pii: S0896-8411(17)30768-0. doi: 10.1016/j.jaut.2017.11.006. [Epub ahead of print] Review.

18.

Therapeutic targeting of STAT pathways in CNS autoimmune diseases.

Egwuagu CE, Larkin Iii J.

JAKSTAT. 2013 Jan 1;2(1):e24134. doi: 10.4161/jkst.24134. Review.

19.

Interactions between Type 1 Interferons and the Th17 Response in Tuberculosis: Lessons Learned from Autoimmune Diseases.

Mourik BC, Lubberts E, de Steenwinkel JEM, Ottenhoff THM, Leenen PJM.

Front Immunol. 2017 Apr 5;8:294. doi: 10.3389/fimmu.2017.00294. eCollection 2017. Review.

20.

Immunoinflammatory diseases of the central nervous system - the tale of two cytokines.

Hofer MJ, Campbell IL.

Br J Pharmacol. 2016 Feb;173(4):716-28. doi: 10.1111/bph.13175. Epub 2015 Jun 12. Review.

Supplemental Content

Support Center